You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Surgical Therapy for Hepatocellular Carcinoma: Formulating a Rational Approach

Cha, Charles MD

Journal of Clinical Gastroenterology:
doi: 10.1097/MCG.0b013e31829440bd
Presentations
Abstract

Hepatocellular carcinoma is one of the most common malignancies worldwide, and its incidence continues to rise in the United States. Partial hepatectomy and liver transplantation remains the mainstay of treatment for localized disease and provides significant improvement in long-term survival, as well as the potential for cure. The indications and criteria for resection and transplantation are well established, but continue to undergo significant modification over time. Surgical resection is the primary therapeutic modality in patients with well-compensated liver disease, and transplantation is highly effective in early-stage tumors in patients with severe underlying liver disease. The relative role for each of these modalities must be tailored to individual patients based on a rational approach designed to balance quality of life, organ allocation, and patient survival.

Author Information

Department of Surgical Oncology and GI Surgery, Yale University School of Medicine, New Haven, CT

The author declares that there is nothing to disclose.

Reprints: Charles Cha, MD, Department of Surgical Oncology and GI Surgery, Yale University School of Medicine, 330 Cedar St, FMB 130, New Haven, CT 06510 (e-mail: charles.cha@yale.edu).

© 2013 by Lippincott Williams & Wilkins